Search Brexit News

ad

AstraZeneca breast cancer drug Lynparza is approved by EU regulators

AstraZeneca breast cancer drug Lynparza is approved by EU regulators
Lynparza has been approved by the European Commission to treat patients suffering from a type of high-risk, early-stage breast cancer.

* This article was originally published here

No comments:

Post a Comment